DEBORAH J ANDREWS Insider Trading $BTX Lineage Cell Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DEBORAH J ANDREWS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DEBORAH J ANDREWS. DEBORAH J ANDREWS is Chief Financial Officer in STAAR SURGICAL CO ($STAA) and Vice President in STAAR SURGICAL CO ($STAA) and VP & Chief Financial Officer in STAAR SURGICAL CO ($STAA) and Director in BIOTIME INC ($BTX).
DEBORAH J ANDREWS in Lineage Cell Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DEBORAH J ANDREWS: Director
Holdings: 10,000 shares
Current Value: $30,600
Latest Transaction: Jul 02 2020
$BTX Market Capitalization: $309.34M
$BTX Previous Close: $3.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DEBORAH J ANDREWS in Lineage Cell Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 02 2020 | BTX | Lineage Cell Thera ... | ANDREWS DEBORAH J | Director | Option Exercise | A | 0.83 | 40,000 | 33,052 | 40,000 | |
| Jul 03 2019 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Option Exercise | A | 1.03 | 40,000 | 41,200 | 40,000 | |
| Sep 13 2018 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Buy | P | 2.35 | 1,604 | 3,769 | 10,000 | 8.4 K to 10 K (+19.10 %) |
| Jul 03 2018 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Option Exercise | A | 2.06 | 40,000 | 82,400 | 40,000 | |
| Aug 23 2017 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Buy | P | 2.50 | 2,396 | 5,990 | 8,396 | 6 K to 8.4 K (+39.93 %) |
| Jul 05 2017 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Option Exercise | A | 3.15 | 20,000 | 63,000 | 20,000 | |
| Jun 21 2017 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Buy | P | 2.95 | 2,000 | 5,900 | 6,000 | 4 K to 6 K (+50.00 %) |
| May 17 2017 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Buy | P | 3.21 | 2,000 | 6,410 | 4,000 | 2 K to 4 K (+100.00 %) |
| Jul 05 2016 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Option Exercise | A | 2.72 | 20,000 | 54,400 | 20,000 | |
| Aug 26 2015 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Buy | P | 2.82 | 2,000 | 5,640 | 2,000 | 0 to 2 K |
| Jul 06 2015 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Option Exercise | A | 3.57 | 20,000 | 71,400 | 20,000 | |
| Jul 03 2014 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Option Exercise | A | 3.11 | 20,000 | 62,200 | 20,000 |
Page: 1